[{"address1": "2265 Upper Middle Road East", "address2": "Suite 602", "city": "Oakville", "state": "ON", "zip": "L6H 0G5", "country": "Canada", "phone": "289 910 0850", "fax": "905 481 2394", "website": "https://www.cardiolrx.com", "industry": "Drug Manufacturers - Specialty & Generic", "industryKey": "drug-manufacturers-specialty-generic", "industryDisp": "Drug Manufacturers - Specialty & Generic", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases. Its lead product candidate is CardiolRx, which is in Phase II multi-national, randomized, double-blind, and placebo-controlled study to evaluate the efficacy and safety of CardiolRx in acute myocarditis, as well as for the treatment of recurrent pericarditis. The company is also developing CRD-38 injection for subcutaneous administration that is in preclinical development for the treatment of heart failure. It has a license agreement with Meros. The company was incorporated in 2017 and is headquartered in Oakville, Canada.", "companyOfficers": [{"maxAge": 1, "name": "Mr. David G. Elsley MBA", "title": "President, CEO & Director", "fiscalYear": 2023, "totalPay": 522742, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Christopher J. Waddick C.A., C.M.A., CPA, CMA, MBA", "title": "CFO, Corporate Secretary & Director", "fiscalYear": 2023, "totalPay": 205994, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Bernard  Lim B.Sc.", "title": "Chief Operating Officer", "fiscalYear": 2023, "totalPay": 360490, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Andrew Warwick Hamer M.D.", "age": 62, "title": "Chief Medical Officer & Head of Research & Development", "yearBorn": 1962, "fiscalYear": 2023, "totalPay": 521668, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Trevor  Burns", "title": "Investor Relations", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. John A. Geddes BSCPT, MBA", "title": "Vice President of Corporate Development", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 7, "boardRisk": 4, "compensationRisk": 10, "shareHolderRightsRisk": 3, "overallRisk": 7, "governanceEpochDate": 1743465600, "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.91, "open": 0.91, "dayLow": 0.81, "dayHigh": 0.9265, "regularMarketPreviousClose": 0.91, "regularMarketOpen": 0.91, "regularMarketDayLow": 0.81, "regularMarketDayHigh": 0.9265, "payoutRatio": 0.0, "beta": 0.573, "forwardPE": -2.612903, "volume": 224694, "regularMarketVolume": 224694, "averageVolume": 250446, "averageVolume10days": 249930, "averageDailyVolume10Day": 249930, "bid": 0.63, "ask": 1.05, "bidSize": 1, "askSize": 2, "marketCap": 69796408, "fiftyTwoWeekLow": 0.81, "fiftyTwoWeekHigh": 3.12, "fiftyDayAverage": 1.1789, "twoHundredDayAverage": 1.6696, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 63419964, "profitMargins": 0.0, "floatShares": 77722363, "sharesOutstanding": 82609000, "sharesShort": 1763320, "sharesShortPriorMonth": 1475679, "sharesShortPreviousMonthDate": 1739491200, "dateShortInterest": 1741910400, "sharesPercentSharesOut": 0.0216, "heldPercentInsiders": 0.04003, "heldPercentInstitutions": 0.10233, "shortRatio": 6.24, "shortPercentOfFloat": 0.0224, "impliedSharesOutstanding": 86168400, "bookValue": 0.149, "priceToBook": 5.4362416, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1727654400, "netIncomeToCommon": -36136008, "trailingEps": -0.36, "forwardEps": -0.31, "enterpriseToEbitda": -1.661, "52WeekChange": -0.5691489, "SandP52WeekChange": -0.024663687, "quoteType": "EQUITY", "currentPrice": 0.81, "targetHighPrice": 9.880433, "targetLowPrice": 8.052469, "targetMeanPrice": 8.821036, "targetMedianPrice": 8.675622, "recommendationMean": 1.8, "recommendationKey": "buy", "numberOfAnalystOpinions": 4, "totalCash": 15885018, "totalCashPerShare": 0.195, "ebitda": -38172776, "totalDebt": 165984, "quickRatio": 2.323, "currentRatio": 2.485, "debtToEquity": 1.591, "returnOnAssets": -0.7907, "returnOnEquity": -1.59533, "freeCashflow": -12152216, "operatingCashflow": -25932334, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "CAD", "symbol": "CRDL", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "marketState": "CLOSED", "corporateActions": [], "postMarketTime": 1743806121, "regularMarketTime": 1743796803, "exchange": "NCM", "messageBoardId": "finmb_424954803", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -10.989014, "regularMarketPrice": 0.81, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1547562600000, "postMarketChangePercent": 14.8148, "postMarketPrice": 0.93, "postMarketChange": 0.12, "regularMarketChange": -0.100000024, "regularMarketDayRange": "0.81 - 0.9265", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 250446, "fiftyTwoWeekLowChange": 0.0, "fiftyTwoWeekLowChangePercent": 0.0, "fiftyTwoWeekRange": "0.81 - 3.12", "fiftyTwoWeekHighChange": -2.31, "fiftyTwoWeekHighChangePercent": -0.74038464, "fiftyTwoWeekChangePercent": -56.91489, "earningsTimestampStart": 1744056000, "earningsTimestampEnd": 1744574400, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -0.36, "epsForward": -0.31, "epsCurrentYear": -0.38, "priceEpsCurrentYear": -2.131579, "fiftyDayAverageChange": -0.3689, "fiftyDayAverageChangePercent": -0.3129188, "twoHundredDayAverageChange": -0.8596, "twoHundredDayAverageChangePercent": -0.51485384, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-08-10", "averageAnalystRating": "1.8 - Buy", "cryptoTradeable": false, "shortName": "Cardiol Therapeutics Inc.", "longName": "Cardiol Therapeutics Inc.", "displayName": "Cardiol Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-04-05"}]